$CL (-1,09 %)

🔹 Adj. EPS: $0.91 🟢 (Est. $0.86) | +6% YoY

🔹 Revenue: $4.91B 🟢 (Est. $4.89B) | -3.1% YoY

🔹 Organic Sales: +1.4% YoY

Guidance (FY25)

🔹 Organic Sales Growth: +2% to +4% (Est. +3.36%) 😐

🔹 EPS Growth: Low single digits

🔹 FX expected to be a low-single-digit headwind

Segment Performance

🔹 North America: Organic Sales -3.0%

🔹 Latin America: Organic Sales +4.0%

🔹 Europe: Organic Sales +5.4%

🔹 Hill’s Pet Nutrition: Organic Sales +2.9%

Operating Metrics

🔹 Gross Margin: +80 bps to 60.8%

🔹 Advertising Spend: +30 bps to 13.6% of sales

CEO Commentary

🔸 Focused on agility amid volatility; reaffirmed commitment to financial targets.

🔸 Tariff impacts included in outlook; FX remains a headwind.

$CL (-1,09 %)

In Q4 2024, Colgate-Palmolive maintained its leadership in oral care but faced slight revenue declines. Despite a 0.1% drop in net sales, organic sales grew 4.3%, supported by price increases and strong performance in key markets. The company continued to invest in marketing (+15% YoY), digital transformation, and innovation to sustain long-term growth.

📊 Income Statement Highlights (Q4 2024 vs. Q4 2023)

▫️Net Income: $739M vs. $718M (+3%)

▫️Total Revenue: $4.94B vs. $4.95B (-0.1%)

▫️Adjusted EPS: $0.91 vs. $0.87 (+5%)

▫️Gross Margin: 60.3% vs. 59.6% (+70 bps)

▫️Operating Income: $1.06B vs. $1.07B (-1%)

▫️Non-GAAP Operating Margin: 21.7% (flat YoY)

▫️GAAP Operating Margin: 21.5% (-20 bps)

▫️Operating Cash Flow: $4.1B (+10% YoY)

▫️Advertising Expense: $648M (+15% YoY)

▫️Hill’s Pet Nutrition Revenue: $1.14B (+2.3%)

💼 Balance Sheet Highlights (Q4 2024 vs. Q4 2023)

▫️Total Assets: $16.05B vs. $15.82B

▫️Total Liabilities: $15.50B vs. $15.33B

▫️Cash & Equivalents: $1.10B (+13.5%)

▫️Debt: $7.95B

▫️Equity: $212M (↓ due to share buybacks)

▫️Free Cash Flow: $3.55B (+9.5%)

🔮 Future Outlook

2025 Guidance:

▫️Net sales expected to be flat due to FX headwinds (~5% impact).

▫️Organic sales growth of 3-5%, in line with long-term targets.

▫️Gross margin expansion driven by pricing and efficiency gains.

▫️Flat to slightly higher advertising spend to drive brand momentum.

▫️Mid-single-digit EPS growth, despite expected private label pet nutrition exit.

Colgate is well-positioned to sustain growth through brand investment, cost optimization, and global market leadership.

$CL (-1,09 %) is next buy

$CL (-1,09 %) | Colgate-Palmolive Q3'24 Earnings Highlights

🔹 Revenue: $5.03B (Est. $5.01B) 🟢; UP +2.4% YoY

🔹 Base Business EPS: $0.91 (Est. $0.88) 🟢; UP +6% YoY

Narrowed FY24 Guidance:

🔹 Net Sales Growth: 3%-5% (Prev. 2%-5%)

🔹 Organic Sales Growth: 7%-8% (Prev. 6%-8%)

🔹 Non-GAAP EPS Growth: 10%-11% (Prev. 8%-11%)

Key Performance Metrics:

🔹 Organic Sales Growth: +6.8%

🔹 Gross Profit Margin (GAAP): 61.1% (vs. 58.5% YoY) 

🔹 Base Business Gross Profit Margin: 61.3%; UP +270 bps YoY

Divisional Organic sales :

🔸 North America: -1.9%

🔸 Latin America: +14.2%

🔸 Europe: +6.3%

🔸 Asia Pacific: +6.1%

🔸 Hill's Pet Nutrition: +6.5%